Brazil Revises Procedures for Imports of COVID-19-Related Medicine, Vaccines
Brazil recently introduced new requirements surrounding imports of medicines to combat and vaccines to prevent COVID-19, the Hong Kong Trade Development Council reported May 5. Those imports must be “specifically indicated for the treatment or prevention” of COVID-19, must be…
Sign up for a free preview to unlock the rest of this article
Timely, relevant coverage of court proceedings and agency rulings involving tariffs, classification, valuation, origin and antidumping and countervailing duties. Each day, Trade Law Daily subscribers receive a daily headline email, in-depth PDF edition and access to all relevant documents via our trade law source document library and website.
approved by a foreign health authority and must have “at least Phase 3 clinical studies completed or with provisional results,” HKTDC said. The country also simplified other procedures around importing “priority medical devices and medicines” that aren’t authorized in Brazil on a “temporary and exceptional basis.” Those products must be prequalified by the World Health Organization or meet other foreign regulatory standards, HKTDC said, and must prove compliance with “good manufacturing practices.”